Market Overview
Global Spirometer Market is size accrued earnings worth approximately USD 1.1 Billion in 2023 and is predicted to gain revenue of about USD 2.62 Billion by 2032, is set to record a CAGR of nearly 10% over the period from 2024 to 2032.
Expected factors that will spur the market growth are an increase in the prevalence of chronic respiratory diseases, the preference for home healthcare, and technological advancements. According to the World Health Organization, 90% of the world's population breathes polluted air. Different types of pollutants and irritants cause a host of adverse effects on the lungs.
Spirometry equipment is helpful in diagnosing several respiratory disorders, including obstructive chronic lung disease, emphysema, asthma, and other breathing disorders for screening in an occupational environment. Rising cases of COPD globally will increase the demand for spirometers in the coming years.
Thus, companies are also introducing spirometers that have a much better design along with more attractive features to the patients as well as the doctors to simplify the complicated procedure that is applied in pulmonary function testing. This improves their yield and also provides comfort to patients without any complications. Moreover, companies also adapt novel packaging procedures to prevent some form of bacterial infection. Therefore, such technological advancements make the testing procedures straightforward and easy to be administered to the patients.
Use of spirometry in asthma diagnosis is not a very common activity, especially for children in most countries with poorer resource inputs; most such areas tend to carry the burden of a high disease level of non-communicable diseases. Spirometry-based evaluation increases its utility in disease diagnosis, therefore relieving people from non-communicable disease-related burden. Improved paediatric health services and highly standardized spirometry test instruments along with short testing time, as these enable patients to see a rapid reaction toward their spirometry reports.
In recent times, the trend for home care has increased in patients. The idea of offering treatment to patients at their own home is one of the most important factors that drive the market. The increase in preference for home care led to the invention of tele-spirometers.
An ageing population is one of the primary drivers that have been fuelling the growth in the market. This age group is prone to a range of chronic respiratory disorders that can be diagnosed through spirometry. Furthermore, the increasing awareness among consumers about high-end diagnostic procedures is also expanding the market growth.
Numerous technical improvements, such as the emergence of compact and portable spirometers that connect to smart devices, have made it possible for clinicians and hospitals to readily obtain patient data. Increased R&D to develop more efficient products is also predicted to boost the growth of the market.
Market Drivers
Rising Prevalence of Respiratory Diseases
A growing number of cases of chronic obstructive pulmonary disease (COPD), asthma, and other respiratory diseases are fuelling the demand for spirometers. COPD, or chronic obstructive pulmonary disease, is a progressive lung disease often caused by smoking and environmental air pollutants. It has increased globally, mainly among the elderly. Asthma cases have also followed the same trend because their cases have gradually increased due to urbanization, increased levels of air pollution, and changes in people's lifestyles. These conditions require continuous monitoring of lung function to follow the progression of the disease and the effectiveness of the treatment; hence, spirometry becomes an essential diagnostic tool. Increased concern towards pulmonary health from respiratory complications because of infections like COVID-19 has also helped to increase demand for spirometers. The seriousness of the complications can be prevented with early diagnosis and monitoring. It prevents serious complications and decreases hospital admissions. Health providers and governments in various countries today focus on an early diagnosis of lung diseases. Spirometry test is endorsed for routine practices in hospitals and clinics and also in homes. This again increases the global market for spirometers with an increased number of respiratory illness burden.
Market Opportunities
Integration with Electronic Health Records (EHRs)
Spirometers aid in diagnosis and treatment planning as well as data management since it is a point of one-stop access to patient respiratory data. Because the results of spirometry get automatically documented into EHRs, health care professionals can follow the trends of lung function with time, thus enabling early identification of conditions such as COPD and asthma. This minimizes errors due to manual entry of data, improves workflow, and provides the proper documentation of pulmonary health. Traditionally, by observing the spirometry data and correlating with other medical history data, the options for treatment could be much more ideal while adjusting therapies and medications. There is also coordinated care made possible by the potential of interoperable healthcare teams concerning chronic conditions, and access to that enables patients to participate in better outcomes through data monitoring done remotely through telemedicine visits. Spirometers also integrated into the EHR help streamline pulmonary diagnostics and monitoring towards improvements in patient outcome, fewer trips to the hospitals, and even broader efficiency within respiratory health management.
Market Restraining Factors
High Cost of Advanced Spirometers
The high cost of advanced spirometers is a major limitation to their adoption, especially in cost-sensitive regions where healthcare budgets are limited. Many developing countries and low-income healthcare facilities cannot afford sophisticated pulmonary function testing equipment, which often includes digital or portable spirometers with advanced data integration capabilities. The initial investment, along with maintenance and calibration costs, can further strain financial resources. Thus, not all of them may have proper policies covering the reimbursement regarding the lung function tests; thereby the cost being extremely high associated with the buying of spirometers discourages many providers to get them. Due to such inadequacy, many hospitals fall back on either obsolete or low sensitivity spirometry devices and solutions, losing early detection of respiratory illnesses such as COPD and asthma, or inefficient management, thus raising future costs in the delivery of health services. This challenge requires low-cost innovation, government support, and other pricing models so that spirometry can be made more accessible for the underserved populations.
Segmentation Analysis
The market scope is segmented because of by Product Type, by Mechanism, by Application, by End-User, by region.
Based on the Product Type of the market is segmented into Handheld Spirometers, Tabletop Spirometers, Desktop Spirometers.
The market for spirometers is dominated by handheld spirometers because of their portability, affordability, and increasing adoption in home healthcare and primary care settings. These compact devices allow patients and healthcare providers to conduct lung function tests conveniently, making them ideal for monitoring chronic respiratory conditions such as asthma and COPD. Handheld spirometers are usually accompanied by digital displays along with Bluetooth connectivity and can be remotely shared with physicians. The MIR Smart One is one such portable spirometer that synchronizes with smartphones to track real-time respiratory activity.
Tabletop spirometers are hospital-grade, bulky devices that are used for a more detailed analysis of pulmonary functions. These are used extensively in hospitals, clinics, and diagnostic centres because they are very accurate and come with features like graphical data representation along with electronic health records. For instance, ndd EasyOne Pro is highly accurate in diagnosing lung diseases.
Advanced lung tests are desktop spirometers, especially used in specialized diagnostic laboratories. They also provide sophisticated data handling and analysis facilities. For example, the KoKo Legend II system offers high-resolution output that can be applicable in clinical research and use in hospitals.
Based on the Mechanism of the market is segmented into Flow-Sensing Spirometers, Volume-Based Spirometers, Peak Flow Meters.
The market for spirometers is dominated by flow-sensing spirometers, as they are very accurate and easy to use. They are applied in both clinical and home settings. These devices measure airflow rates during inhalation and exhalation using sensors such as pneumotachographs or ultrasonic technology. The real-time data provided by the device makes it ideal for diagnosing and monitoring respiratory conditions such as COPD and asthma. An example is the ndd EasyOne Air, a portable, digital flow-sensing spirometer known for its precision and reliability in pulmonary function testing.
Volume-based spirometers measure lung capacity by recording the total volume of air inhaled or exhaled. They are often used in hospitals and research facilities for complete pulmonary evaluation. In contrast to flow-sensing models, they need a larger setup and may use water-sealed or bellows mechanisms. A well-known example is the Vitalograph Compact, which provides detailed lung volume measurements for diagnostic purposes.
Peak flow meters are relatively simple, portable devices that help measure peak expiratory flow, which denotes how well the air is evacuated from the lungs. They have become a vital tool for most asthma self-management programs. A very popular type of peak flow meter is Philips Respironics Personal Best.
By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA are provided by the study. North America dominated the market share with 41.6% of its market in 2022 is primarily owing to the rising incidence of respiratory diseases. Spirometers aid in the control of diseases and are used by doctors for the treatment of a high number of cases of asthma and COPD in hospitals. Besides, the United States is identified as one of the first users of technologies that reduce the rates of COPD. Thus, because of the foregoing, the market will grow in the forecast period.
Asia Pacific is expected to grow the fastest at an 11.1% compound annual growth rate during the forecast period. The improving primary care activities for early detection and management of chronic lung disorders such as COPD and asthma are expected to drive the Asia Pacific market during the forecast period.
List of Companies Profiled
- Schiller
- Smith’s Medical
- Vyaire Medical, Inc.
- SDI Diagnostics
- nSpire Health Inc.
- Fukuda Sangyo Co. Ltd.
- Sibelmed
- Vitalograph
- Geratherm Respiratory AG
- Koninklijke Philips N.V.
- Welch Allyn.
Report Coverage
The report will cover the qualitative and quantitative data on the Global Spirometer Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.
Report Scope and Segmentations
Study Period | 2024-32 |
Base Year | 2023 |
Estimated Forecast Year | 2024-32 |
Growth Rate | CAGR of 10% from 2024 to 2032 |
Segmentation | By Product Type, By Mechanism, By Application, By End-User, By Region |
Unit | USD Million |
By Product Type | - Handheld Spirometers
- Tabletop Spirometers
- Desktop Spirometers
|
By Mechanism | - Flow-Sensing Spirometers
- Volume-Based Spirometers
- Peak Flow Meters
|
By Application | - Chronic Obstructive Pulmonary Disease (COPD) Diagnosis & Monitoring
- Asthma Management
- Cystic Fibrosis Monitoring
- Post-Surgical Respiratory Assessment,
- Occupational Health Testing
|
By End-User | - Hospitals & Clinics
- Home Healthcare Settings
- Diagnostic Laboratories,
- Academic & Research Institutions
|
By Region | - North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
- Asia-Pacific (China, India, Japan, ASEAN, Rest of Asia-Pacific)
- Latin America (Brazil, Mexico, Rest of Latin America)
- MEA (Saudi Arabia, South Africa, UAE, Rest Of MEA)
|
Global Spirometer Market Regional Analysis
North America accounted for the highest xx% market share in terms of revenue in the Spirometer market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Spirometer. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Spirometer companies in economies such as Japan and China.
The objective of the report is to present comprehensive analysis of Global Spirometer Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.
Spirometer Market Report is also available for below Regions and Country Please Ask for that
North America
Europe
- Switzerland
- Belgium
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherland
- Turkey
- Rest of Europe
Asia-Pacific
- India
- Australia
- Philippines
- Singapore
- South Korea
- Japan
- China
- Malaysia
- Thailand
- Indonesia
- Rest Of APAC
Latin America
- Mexico
- Argentina
- Peru
- Colombia
- Brazil
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest Of MEA
Points Covered in the Report
- The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
- The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 5 years data history and forecast.
- The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
- Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
- The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Questions
- How much the global Spirometer Market valued?
- Which region has the largest share in 2024 for the global Spirometer Market?
- What are the driving factors for the market?
- Which is the leading segment in the global market?
- What are the major players in the market?
Research Scope of Spirometer Market
- Historic year: 2019- 2022
- Base year: 2023
- Forecast: 2024 to 2032
- Representation of Market revenue in USD Billion